olaparib,bevacizumab
roche,astrazeneca,merck
['avastin', 'lynparza', '$azn', '$mrk']
$azn $mrk #esmo22: at five-year mark, lynparza kept more patients alive than avastin but missed overall os significance - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities